| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-141-2-200407200-00013 |
| P698 | PubMed publication ID | 15262670 |
| P50 | author | Simin Liu | Q25999435 |
| Meir J Stampfer | Q80164992 | ||
| P2093 | author name string | Yiqing Song | |
| P2860 | cites work | The effect of a gender difference in the apolipoprotein E gene DNA polymorphism on serum lipid levels in a Serbian healthy population | Q40747951 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 137-147 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease | |
| P478 | volume | 141 |
| Q44657827 | A direct assessment of genetic contribution to the incidence of coronary infarct in the general population Greek EPIC cohort |
| Q48957935 | A high cholesterol diet given to apolipoprotein E-knockout mice has a differential effect on the various neurotrophin systems in the hippocampus. |
| Q43244342 | A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss |
| Q38748440 | A randomized trial and novel SPR technique identifies altered lipoprotein-LDL receptor binding as a mechanism underlying elevated LDL-cholesterol in APOE4s |
| Q38162891 | A systematic review of the factors associated with interest in predictive genetic testing for obesity, type II diabetes and heart disease |
| Q51386266 | APOE -491 T allele may reduce the risk of atherosclerotic lesions among middle-aged women. |
| Q35778546 | APOE Polymorphism Is Associated with C-reactive Protein Levels but Not with White Blood Cell Count: Dong-gu Study and Namwon Study |
| Q35771983 | APOE alleles are not associated with calcific aortic stenosis |
| Q35220171 | APOE and FABP2 Polymorphisms and History of Myocardial Infarction, Stroke, Diabetes, and Gallbladder Disease. |
| Q45968013 | APOE gene polymorphisms and response to statin therapy. |
| Q38663579 | APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome |
| Q33979119 | APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels |
| Q58547737 | APOE4 Genotype Exerts Greater Benefit in Lowering Plasma Cholesterol and Apolipoprotein B than Wild Type (E3/E3), after Replacement of Dietary Saturated Fats with Low Glycaemic Index Carbohydrates |
| Q33445395 | Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study |
| Q48340994 | Age differences in arterial and venous extra-cerebral blood flow in healthy adults: contributions of vascular risk factors and genetic variants |
| Q37533800 | Age, gender, and cancer but not neurodegenerative and cardiovascular diseases strongly modulate systemic effect of the Apolipoprotein E4 allele on lifespan |
| Q35981917 | Age-Related Macular Degeneration and Coronary Artery Disease in a VA Population |
| Q44874657 | Age-dependent interaction of apolipoprotein E gene with eastern birthplace in Finland affects severity of coronary atherosclerosis and risk of fatal myocardial infarction--Helsinki Sudden Death Study |
| Q35843108 | Age-related differences in memory and executive functions in healthy APOE ɛ4 carriers: the contribution of individual differences in prefrontal volumes and systolic blood pressure |
| Q37281552 | Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study |
| Q28660578 | Age-related macular degeneration and the incidence of cardiovascular disease: a systematic review and meta-analysis |
| Q59711742 | Age-related trends of blood pressure levels by apolipoprotein E genotype: the Bambuì cohort study of ageing (1997–2008) |
| Q36099647 | An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease |
| Q33926622 | An updated meta-analysis: apolipoprotein E genotypes and risk of primary open-angle glaucoma |
| Q80478902 | ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome |
| Q44492251 | ApoE gene polymorphism and vascular dementia in Chinese population: a meta-analysis |
| Q36804822 | ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation |
| Q38008109 | ApoE genotype: from geographic distribution to function and responsiveness to dietary factors |
| Q35070590 | ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects. |
| Q55668951 | Apolipoprotein E (ApoE) polymorphism is related to differences in potential fertility in women: a case of antagonistic pleiotropy? |
| Q34013483 | Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly |
| Q36428621 | Apolipoprotein E gene is related to mortality only in normal weight individuals: the Rotterdam Study |
| Q33735872 | Apolipoprotein E gene polymorphism and dyslipidaemia in adult Asian Indians: A population based study from Calcutta, India |
| Q36686234 | Apolipoprotein E gene polymorphism and its effect on anthropometric measures in normoglycemic subjects and type 2 diabetes |
| Q35154972 | Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls |
| Q38860658 | Apolipoprotein E gene polymorphism and the risk of subarachnoid hemorrhage: a meta-analysis of case-control studies |
| Q47144648 | Apolipoprotein E gene polymorphism modifies fasting total cholesterol concentrations in response to replacement of dietary saturated with monounsaturated fatty acids in adults at moderate cardiovascular disease risk |
| Q28544622 | Apolipoprotein E gene polymorphisms are associated with primary hyperuricemia in a Chinese population |
| Q27491003 | Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review |
| Q33756098 | Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm |
| Q52879007 | Apolipoprotein E genotype status affects habitual human blood mononuclear cell gene expression and its response to fish oil intervention. |
| Q46535385 | Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application. |
| Q38230137 | Apolipoprotein E polymorphism and colorectal neoplasm: results from a meta-analysis |
| Q40762156 | Apolipoprotein E polymorphism and functional disability in Brazilian elders: the Bambuí Health and Aging Study |
| Q35058300 | Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study |
| Q64899447 | Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia. |
| Q37310712 | Apolipoprotein E-polymorphism, frailty and mortality in older adults |
| Q34080448 | Apolipoprotein E-related all-cause mortality in hospitalized elderly patients. |
| Q57305183 | Apolipoprotein E/C1/C4/C2 Gene Cluster Diversity in Two Native Andean Populations: Aymaras and Quechuas |
| Q38686493 | Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study |
| Q36201919 | Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress |
| Q39534946 | Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden |
| Q34415899 | Apolipoprotein E4 is deficient in inducing macrophage ABCA1 expression and stimulating the Sp1 signaling pathway |
| Q36966031 | Apolipoprotein polymorphisms and familial hypercholesterolemia |
| Q85655999 | Apolipoprotein ε4-allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer's disease: a meta-analysis of prospective studies |
| Q30578906 | Application of an integrative computational framework in trancriptomic data of atherosclerotic mice suggests numerous molecular players. |
| Q37897474 | Arterial thrombus formation in cardiovascular disease |
| Q40247745 | Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition |
| Q37114815 | Association between APOE, SCARB1, PPARα polymorphisms and serum lipids in a population of Lithuanian adults |
| Q34567051 | Association between Apolipoprotein E Polymorphism and Chronic Kidney Disease in the Korean General Population: Dong-gu Study. |
| Q36260764 | Association between Apolipoprotein E polymorphism and myocardial infarction risk: A systematic review and meta-analysis |
| Q34796247 | Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Chinese population: evidence from a meta-analysis of 40 studies |
| Q36959155 | Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke |
| Q33735609 | Association of ALS with head injury, cigarette smoking and APOE genotypes |
| Q36307711 | Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population |
| Q28302842 | Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome |
| Q33844606 | Association of apolipoprotein E and angiotensin converting enzyme gene polymorphisms with the multidimensional impairment in older patients. |
| Q53070205 | Association of apolipoprotein E gene polymorphisms with blood lipids and their interaction with dietary factors. |
| Q46835614 | Association of apolipoprotein E genotype with early onset of coronary heart disease in Greek men. |
| Q91832247 | Association of apolipoprotein E genotypes with epilepsy risk: A systematic review and meta-analysis |
| Q35800874 | Association of genetic variants and incident coronary heart disease in multiethnic cohorts: the PAGE study |
| Q28476773 | Associations between APOE variants and metabolic traits and the impact of psychological stress |
| Q36377149 | Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients |
| Q37216782 | Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties |
| Q28383805 | Buying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's disease |
| Q94599763 | Causal association of circulating cholesterol levels with dementia: a mendelian randomization meta-analysis |
| Q28472816 | Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants |
| Q47587631 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry |
| Q36772067 | Clinical study of isosorbide mononitrate treatment for angina pectoris in coronary heart disease |
| Q24683646 | Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association |
| Q36089519 | Coronary heart disease and polymorphisms in genes affecting lipid metabolism and inflammation |
| Q36020536 | Coronary risk correlates with cerebral amyloid deposition |
| Q57038754 | Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis |
| Q42958255 | Determinants of paraoxonase activity in healthy adults |
| Q28768666 | Diagnosis and treatment of non-hemodynamically significant coronary heart disease: where to start? |
| Q84906931 | Dietary fat and apolipoprotein genotypes modulate plasma lipoprotein levels in Brazilian elderly women |
| Q40155000 | Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages |
| Q37164458 | Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial |
| Q34643186 | Diversity of apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of metabolic syndrome among hypertensive patients |
| Q33901461 | Does APOE genotype modify the relations between serum lipid and erythrocyte omega-3 fatty acid levels? |
| Q83141007 | Does Apolipoprotein E genotype affect cardiovascular risk in subjects with acromegaly? |
| Q36356533 | Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. |
| Q97880125 | Does polymorphisms in PPAR and APOE genes modify associations between FADS, n-3 long-chain polyunsaturated fatty acids, and cardiometabolic markers in 8-11 year-old Danish children? |
| Q37720716 | Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics |
| Q43892427 | Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program |
| Q42444435 | Effect of apoE genotype and dietary quercetin on blood lipids and TNF-alpha levels in apoE3 and apoE4 targeted gene replacement mice |
| Q83259191 | Effect of apolipoprotein E genotypes on incidence and development of coronary stenosis in Iranian patients with coronary artery disease |
| Q36935652 | Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1. |
| Q40148295 | Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression |
| Q34400491 | Emerging clinical applications in cardiovascular pharmacogenomics |
| Q37877334 | Emerging genomic applications in coronary artery disease |
| Q36636219 | Ethical and clinical practice considerations for genetic counselors related to direct-to-consumer marketing of genetic tests |
| Q28750270 | Evaluating the causal relevance of diverse risk markers: horizontal systematic review |
| Q39428145 | Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer's disease. |
| Q24336770 | Evidence that the gene encoding insulin degrading enzyme influences human lifespan |
| Q64230315 | Evolutionary Patterns of Non-Coding RNA in Cardiovascular Biology |
| Q34411741 | Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease? |
| Q36303987 | Gene by neuroticism interaction and cognitive function among older adults |
| Q35592025 | Genetic predisposition, nongenetic risk factors, and coronary infarct |
| Q28395880 | Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey |
| Q34218155 | Genetic variants of ApoE and ApoER2 differentially modulate endothelial function |
| Q83770458 | Genetics of cardiovascular disease |
| Q28066981 | Genetics of the acute coronary syndrome |
| Q34588881 | Genomics of heart failure |
| Q38557941 | Greater impact of dietary fat manipulation than apolipoprotein E genotype on ex vivo cytokine production - insights from the SATgenε study |
| Q34137939 | HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging |
| Q42932498 | High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice. |
| Q36642686 | Identification of atherosclerosis-modifying genes: pathogenic insights and therapeutic potential |
| Q34508651 | Impact of APOE gene polymorphisms on the lipid profile in an Algerian population. |
| Q37059819 | Impact of apoE genotype on oxidative stress, inflammation and disease risk |
| Q36763701 | Impact of psychological stress on the associations between apolipoprotein E variants and metabolic traits: findings in an American sample of caregivers and controls |
| Q93080727 | Impact of the Apolipoprotein E (epsilon) Genotype on Cardiometabolic Risk Markers and Responsiveness to Acute and Chronic Dietary Fat Manipulation |
| Q37698495 | Implications of apolipoprotein E genotype on inflammation and vitamin E status |
| Q36487017 | Inflammatory gene variants in the Tsimane, an indigenous Bolivian population with a high infectious load |
| Q46819556 | Influence of apolipoprotein E genotype and dietary alpha-tocopherol on redox status and C-reactive protein levels in apolipoprotein E3 and E4 targeted replacement mice |
| Q36454338 | Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies |
| Q35070055 | KIAA1462, a coronary artery disease associated gene, is a candidate gene for late onset Alzheimer disease in APOE carriers |
| Q46382295 | Kiwifruit consumption favourably affects plasma lipids in a randomised controlled trial in hypercholesterolaemic men. |
| Q58422695 | Linking ecological immunology and evolutionary medicine: the case for apolipoprotein E |
| Q51105427 | Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors. |
| Q38089257 | Lost in translation: five grand challenges for proteomic biomarker discovery |
| Q33764821 | Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis |
| Q33972521 | Major depression and coronary flow reserve detected by positron emission tomography |
| Q36950890 | Mechanisms of disease: The genetic basis of coronary heart disease. |
| Q37145667 | Mechanisms of endothelial dysfunction in obstructive sleep apnea |
| Q36794506 | Meta-analysis for the Association of Apolipoprotein E ε2/ε3/ε4 Polymorphism with Coronary Heart Disease |
| Q35222771 | Meta-analysis of apolipoprotein E gene polymorphism and susceptibility of myocardial infarction |
| Q90233412 | Metabolic and Vascular Effect of the Mediterranean Diet |
| Q36843011 | Molecular genetics of myocardial infarction |
| Q37273667 | Molecular signatures of cardiovascular disease risk: potential for test development and clinical application |
| Q54224064 | New insights into the distribution of APOE polymorphism in the Iberian Peninsula. The case of Andalusia (Spain). |
| Q37138663 | Nutrigenetics and CVD: what does the future hold? |
| Q37401949 | Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there? |
| Q38539222 | Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era. |
| Q36162995 | Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies |
| Q39924246 | Personalized medicine in coronary artery disease: insights from genomic research |
| Q37249836 | Personalized nutrition for the prevention of cardiovascular disease: a future perspective |
| Q37293985 | Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease |
| Q47682467 | Physical Activity in Preventing Alzheimer's Disease and Cognitive Decline: A Narrative Review |
| Q60049384 | Positive association of familial longevity with the moderate-high HDL-C concentration in Bama Aging Study |
| Q36172468 | Poststroke dementia in the elderly. |
| Q42704131 | Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study |
| Q46971513 | Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein. |
| Q47689951 | Relationship between adipokines and lipid profile in postmenopausal women with different apolipoprotein E genotypes |
| Q37671051 | Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects. |
| Q57315159 | Robust association of the APOE ?4 allele with premature myocardial infarction especially in patients without hypercholesterolaemia: the Aachen study |
| Q40331357 | Role of FLAP and PDE4D in myocardial infarction and stroke: target discovery and future treatment options |
| Q37608596 | Role of apolipoprotein E genotype in coronary artery disease |
| Q57711975 | SATgenɛ dietary model to implement diets of differing fat composition in prospectively genotyped groups (apoE) using commercially available foods |
| Q33549649 | Selection on alleles affecting human longevity and late-life disease: the example of apolipoprotein E. |
| Q36002365 | Should mild cognitive impairment be subtyped? |
| Q45768413 | Structural equation modeling of gene-environment interactions in coronary heart disease |
| Q55280703 | Study of the association of 17 lipid-related gene polymorphisms with coronary heart disease. |
| Q33292908 | Subarachnoid hemorrhage: tests of association with apolipoprotein E and elastin genes |
| Q35748369 | Subsets of SNPs define rare genotype classes that predict ischemic heart disease |
| Q35974993 | Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein |
| Q36394541 | The "Mevalonate hypothesis": a cholesterol-independent alternative for the etiology of atherosclerosis |
| Q49163688 | The Associations between Apolipoprotein E Gene Epsilon2/Epsilon3/Epsilon4 Polymorphisms and the Risk of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus. |
| Q24809651 | The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee |
| Q38042547 | The dementia of cardiac disease |
| Q42323402 | The effect of dietary fish oil on weight gain and insulin sensitivity is dependent on APOE genotype in humanized targeted replacement mice. |
| Q37608472 | The effects of apoA-I/C-III/A-IV, apoE and apoB polymorphisms on carotid artery intima-media thickness |
| Q39516222 | The genetic contribution to disease risk and variability in response to diet: where is the hidden heritability? |
| Q36753771 | The impact of EPA and DHA on blood lipids and lipoprotein metabolism: influence of apoE genotype |
| Q33213990 | The key role of apolipoprotein E in atherosclerosis |
| Q38187787 | The obesity paradox: understanding the effect of obesity on mortality among individuals with cardiovascular disease |
| Q33858831 | The potential applications of Apolipoprotein E in personalized medicine |
| Q34603092 | The role of apolipoprotein E in Alzheimer's disease |
| Q36698762 | The role of lipid-related genes, aging-related processes, and environment in healthspan |
| Q54632836 | The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. |
| Q57900672 | The use of Meta-Analysis Risk Estimates for Candidate Genes in Combination to Predict Coronary Heart Disease Risk |
| Q35483474 | Trade-offs in the effects of the apolipoprotein E polymorphism on risks of diseases of the heart, cancer, and neurodegenerative disorders: insights on mechanisms from the Long Life Family Study |
| Q47737005 | Using ApoE Genotyping to Promote Healthy Lifestyles in Finland - Psychological Impacts: Randomized Controlled Trial |
| Q36168772 | Variation in 5' promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: the Copenhagen City Heart Study |
| Q33278272 | Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality |
| Q90586323 | Vascular burden and APOE ε4 are associated with white matter microstructural decline in cognitively normal older adults |
| Q60919917 | Vitamin E Metabolic Effects and Genetic Variants: A Challenge for Precision Nutrition in Obesity and Associated Disturbances |
| Q37570108 | What We Know About Diet, Genes, and Dyslipidemia: Is There Potential for Translation? |
| Q35129501 | What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus |
| Q28291420 | Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history |
Search more.